However, most previously published studies indicated that high- TMB was associated with favorable survival outcomes in different types of malignancies, including melanoma, non-small cell lung cancer (NSCLC), bladder cancer, and HER2-positive refractory metastatic breast cancer 21, 36, 37. The gene discussed is ERBB2; the disease is urinary bladder cancer.